These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8391311

  • 1. Adipocyte beta-adrenoceptor sensitivity influences plasma lipid levels.
    Arner P, Wahrenberg H, Lönnqvist F, Angelin B.
    Arterioscler Thromb; 1993 Jul; 13(7):967-72. PubMed ID: 8391311
    [Abstract] [Full Text] [Related]

  • 2. Importance of beta-adrenoceptor function in fat cells for lipid mobilization.
    Wahrenberg H, Lönnqvist F, Hellmér J, Arner P.
    Eur J Clin Invest; 1992 Jun; 22(6):412-9. PubMed ID: 1321722
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
    Hellström L, Langin D, Reynisdottir S, Dauzats M, Arner P.
    Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
    [Abstract] [Full Text] [Related]

  • 5. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
    Enocksson S, Shimizu M, Lönnqvist F, Nordenström J, Arner P.
    J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
    [Abstract] [Full Text] [Related]

  • 6. Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels.
    Rydén M, Arner P.
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1782-1787. PubMed ID: 28663255
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
    Lönnqvist F, Wahrenberg H, Hellström L, Reynisdottir S, Arner P.
    J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
    [Abstract] [Full Text] [Related]

  • 9. Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
    Barbe P, Galitzky J, De Glisezinski I, Riviere D, Thalamas C, Senard JM, Crampes F, Lafontan M, Berlan M.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):619-25. PubMed ID: 9467583
    [Abstract] [Full Text] [Related]

  • 10. Adiposity, insulin and lipid metabolism in post-menopausal women.
    Lovegrove JA, Silva KD, Wright JW, Williams CM.
    Int J Obes Relat Metab Disord; 2002 Apr; 26(4):475-86. PubMed ID: 12075574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women.
    Berman DM, Nicklas BJ, Ryan AS, Rogus EM, Dennis KE, Goldberg AP.
    Obes Res; 2004 Jan; 12(1):32-9. PubMed ID: 14742840
    [Abstract] [Full Text] [Related]

  • 13. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S, Eriksson M, Angelin B, Arner P.
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [Abstract] [Full Text] [Related]

  • 14. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
    Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M.
    Br J Pharmacol; 1996 Mar; 117(5):907-13. PubMed ID: 8851509
    [Abstract] [Full Text] [Related]

  • 15. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.
    Laakso M, Pyörälä K, Voutilainen E, Marniemi J.
    Am J Epidemiol; 1987 Apr; 125(4):611-21. PubMed ID: 3548333
    [Abstract] [Full Text] [Related]

  • 16. Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in nondiabetic men.
    Poynten AM, Gan SK, Kriketos AD, Campbell LV, Chisholm DJ.
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1035-40. PubMed ID: 15562033
    [Abstract] [Full Text] [Related]

  • 17. Adipocyte triglyceride turnover is independently associated with atherogenic dyslipidemia.
    Frayn K, Bernard S, Spalding K, Arner P.
    J Am Heart Assoc; 2012 Dec; 1(6):e003467. PubMed ID: 23316323
    [Abstract] [Full Text] [Related]

  • 18. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome.
    Langin D.
    Pharmacol Res; 2006 Jun; 53(6):482-91. PubMed ID: 16644234
    [Abstract] [Full Text] [Related]

  • 19. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L, Rössner S, Hagström-Toft E, Reynisdottir S.
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
    [Abstract] [Full Text] [Related]

  • 20. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
    Hellström L, Reynisdottir S, Langin D, Rössner S, Arner P.
    Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.